CSLLY:OTCMKTS
Csl ADR
$31.55
arrow_downward
-0.19%(-0.060) 1D
Sep 8, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSLLY...
Open
$30.23
High
$31.67
Low
$30.23
Mkt. cap
82.29B
Avg. vol.
148.49K
Volume
92.28K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.55
Shares outstanding
479.75M
No. of employees
29K
Open
$30.23
High
$31.67
Low
$30.23
Mkt. cap
82.29B
Avg. vol.
148.49K
Volume
92.28K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.55
Shares outstanding
479.75M
No. of employees
29K
News stories
From web sources and news partners
Kalkine Media
·
5 hours ago
CSL Draws Eyes to Business Resilience (ASX:CSL)
The Motley Fool Australia
·
8 hours ago
Buy, hold, sell: BHP, CSL, CBA shares
The Motley Fool Australia
·
9 hours ago
$10,000 invested in CSL shares in June is now worth…
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About Csl ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com